Latest News

Filters close
Newswise: Mass Eye and Ear appoints Benjamin K. Mizell, MD, as Chief of Anesthesia
Released: 13-Jan-2023 9:50 AM EST
Mass Eye and Ear appoints Benjamin K. Mizell, MD, as Chief of Anesthesia
Massachusetts Eye and Ear

Benjamin K. Mizell, MD, an anesthesiologist with a proven track record of leading major Mass Eye and Ear initiatives including its electronic medical record integration, has been named chief of Anesthesia at Mass Eye and Ear.

29-Nov-2022 10:45 AM EST
New Genetic Mutation Behind Childhood Glaucoma Identified
Massachusetts Eye and Ear

An international team of researchers led by Mass Eye and Ear discovered a new genetic mutation that leads to childhood glaucoma, and in the process uncovered a new mechanism for causing the disease.

Newswise: Cornea Research Pioneer Honored with Prestigious Champalimaud Vision Award
Released: 15-Sep-2022 2:05 PM EDT
Cornea Research Pioneer Honored with Prestigious Champalimaud Vision Award
Massachusetts Eye and Ear

Claes H. Dohlman, MD, Phd, considered a founder of modern cornea science, was awarded the 2022 António Champalimaud Vision Award for his vast contributions to vision research. The award comes with a €1,000,000 prize, one of the largest in scientific research.

Newswise: Artificial Intelligence Model Outperforms Clinicians in Diagnosing Pediatric Ear Infections
Released: 31-Aug-2022 3:10 PM EDT
Artificial Intelligence Model Outperforms Clinicians in Diagnosing Pediatric Ear Infections
Massachusetts Eye and Ear

An artificial-intelligence (AI) model built at Mass Eye and Ear was shown to be significantly more accurate than doctors at diagnosing pediatric ear infections in the first head-to-head evaluation of its kind. The model, called OtoDX, was more than 95 percent accurate in diagnosing an ear infection in a set of 22 test images compared to 65 percent accuracy among a group of clinicians who reviewed the same images.

Released: 16-Aug-2022 11:05 AM EDT
Scientists Uncover Role of Alzheimer’s-Linked APOE Gene in Glaucoma Protection and Identify Promising Treatment Strategy to Prevent Vision Loss
Massachusetts Eye and Ear

Scientists have demonstrated that the APOE4 gene variant, which increases risk for Alzheimer’s but decreases risk of glaucoma in humans, blocks a disease cascade that leads to the destruction of retinal ganglion cells in glaucoma. Additionally, they showed in mouse models that the death of retinal ganglion cells – the cause of vision loss in glaucoma – can be prevented by using medications to inhibit a molecule called Galectin-3, which is regulated by the APOE gene. These findings taken together emphasize the critical role of APOE in glaucoma and suggest that Galectin-3 inhibitors hold promise as a glaucoma treatment, according to the authors.

Released: 25-Jul-2022 10:10 AM EDT
Mass Eye and Ear Researchers Awarded $12.5 Million Nih Grant to Continue Hidden Hearing Loss Research
Massachusetts Eye and Ear

Mass Eye and Ear researchers in the Eaton-Peabody Laboratories have been awarded a five-year, $12.5 million P50 Clinical Research Center Grant from the National Institute on Deafness and Other Communicable Disorders (NIDCD) of the National Institute of Health (NIH) to continue their research on cochlear synaptopathy, or hidden hearing loss, a type of hearing damage first discovered at Mass Eye and Ear in 2009. Funding from the grant extends support of four projects that aim to clarify the prevalence, nature and functional consequences of hidden hearing loss in humans.

Released: 28-Jun-2022 8:00 AM EDT
Researchers Develop Word-Score Model Capable of Estimating Hidden Hearing Loss
Massachusetts Eye and Ear

Researchers from Mass Eye and Ear have developed a word-score model capable of estimating the amount of hidden hearing loss in human ears. This form of hearing loss is caused by cochlear nerve degeneration, and is not detected by standard audiogram tests.

Newswise: Novel Cell Atlas for Multiple Human Tissues Reveals Discoveries Underlying Complex Diseases
12-May-2022 2:00 PM EDT
Novel Cell Atlas for Multiple Human Tissues Reveals Discoveries Underlying Complex Diseases
Massachusetts Eye and Ear

Scientists from the Broad Institute of MIT and Harvard have developed a first-of-its-kind cross-tissue cell atlas, and in collaboration with researchers at Mass Eye and Ear, have uncovered new clues for specific cell types and genes involved in complex diseases. In a new study published May 12 in Science, researchers described for the first time how their novel cross-tissue cell atlas derived from an analysis of nuclei from 25 frozen samples from 8 tissue types may increase understanding of the cellular and genetic underpinnings of complex diseases, including heart disease and cancers.

19-Apr-2022 1:00 PM EDT
Tongue Stimulation Device Reduces Sleep Apnea in Adolescents with Down Syndrome
Massachusetts Eye and Ear

A surgically implanted device that moves the tongue forward during sleep was found to safely and effectively reduce sleep apnea in adolescents with Down syndrome, according to a new study published April 21 in JAMA Otolaryngology – Head & Neck Surgery.

Released: 15-Mar-2022 8:05 AM EDT
Synthetic Viral Vector and Surgical Technique Effectively Deliver Genetic Cargo to Inner Ear in Preclinical Study
Massachusetts Eye and Ear

Mass Eye and Ear research shows the viral vector Anc80L65 efficiently transferred genetic cargo into the inner ear of nonhuman primates via a specialized surgical procedure, paving the way for a method that can be brought to clinical trials for hearing loss and vestibular disorder treatments.

Newswise: HPV-associated Head and Neck Cancer Blood Test Shows Promise as a Test to Replace Tissue Biopsy
1-Dec-2021 11:40 AM EST
HPV-associated Head and Neck Cancer Blood Test Shows Promise as a Test to Replace Tissue Biopsy
Massachusetts Eye and Ear

New research shows liquid biopsy for HPV-associated head and neck cancer is more than 98% accurate and obtained a diagnosis 26 days quicker on average than conventional tissue biopsy, in addition to costing 38% less. With HPV-associated head and neck cancer rates on the rise, there is a great need for more accurate, less-invasive, faster and less expensive diagnostic tests.

Newswise: Mass Eye and Ear Department of Otolaryngology–Head and Neck Surgery Appoints New Senior Vice President
Released: 30-Nov-2021 1:20 PM EST
Mass Eye and Ear Department of Otolaryngology–Head and Neck Surgery Appoints New Senior Vice President
Massachusetts Eye and Ear

Pernell T. Reid, MD, MHA, MS, an experienced health care administrator with nearly two decades of practice management and financial leadership experience in academic medicine, is joining Mass Eye and Ear (a member hospital of Mass General Brigham) as Senior Vice President of the Department of Otolaryngology–Head and Neck Surgery (OHNS).

Released: 5-Oct-2021 7:00 AM EDT
Scientists Identify Role of Protein Behind Rare Norrie Disease; and Find Clues For Treating Hearing Loss
Massachusetts Eye and Ear

Researchers have identified the mechanism that can lead to deafness in the rare syndrome, Norrie disease, which may lead to promising treatment targets for the incurable disease and other forms of profound hearing loss.

Newswise: Mass General Brigham Laryngology Researcher Awarded $11.9 Million NIH Grant to Lead New Multi-Institutional Center for Neurological Voice Disorders
27-Sep-2021 11:55 AM EDT
Mass General Brigham Laryngology Researcher Awarded $11.9 Million NIH Grant to Lead New Multi-Institutional Center for Neurological Voice Disorders
Massachusetts Eye and Ear

Laryngology researcher Kristina Simonyan, MD, PhD, Dr med, of Mass Eye and Ear, has been awarded an $11.9 million P50 Clinical Research Center Grant from the National Institute on Deafness and Other Communicable Disorders to form a new multidisciplinary center across four academic medical institutions that will be committed to conducting research on laryngeal dystonia and voice tremor, two debilitating neurological voice disorders.

Released: 7-Sep-2021 2:45 PM EDT
Lasting Immunity and Protection from New Single-Shot, Room-Temperature Stable COVID-19 Vaccine
Massachusetts Eye and Ear

Gene-based, single-dose AAVCOVID vaccine shown to offer disease protection in challenge study, and to elicit year-long immune response, according to new paper in Cell Host & Microbe.

21-Jul-2021 10:35 AM EDT
Wearable Devices Can Reduce Collision Risk in Blind and Visually Impaired People
Massachusetts Eye and Ear

A wearable computer vision device with vibrating wristbands was shown in a randomized trial to reduce collisions for both people who are blind or those who are visually impaired and using a long cane and/or guide dog by 37 percent, compared to using other mobility aids alone. Such technology may augment safety for independent travel for these individuals.

Released: 6-Jul-2021 10:45 AM EDT
Mass Eye and Ear, Massachusetts General Hospital Appoint Mark Varvares, MD, FACS, Chief of the Departments of Otolaryngology–Head and Neck Surgery
Massachusetts Eye and Ear

Mark Varvares, MD, FACS, has been appointed as the next Chief of the Departments of Otolaryngology-Head and Neck Surgery (OHNS) at Mass Eye and Ear and Massachusetts General Hospital (MGH) and as Chair of the Department of OHNS at Harvard Medical School (HMS), following an extensive year-long search process

Released: 7-May-2021 3:50 PM EDT
Sleep Disorders Tally $94.9 Billion in Health Care Costs Each Year
Massachusetts Eye and Ear

Sleep disorders are associated with significantly higher rates of health care utilization, conservatively placing an additional $94.9 billion in costs each year to the U.S. health care system, according to a new study from researchers at Mass Eye and Ear, a member hospital of Mass General Brigham.

Released: 6-Apr-2021 7:00 AM EDT
Leading Infectious Disease Researcher Appointed Inaugural Chief Scientific Officer at Mass Eye and Ear
Massachusetts Eye and Ear

Michael S. Gilmore, PhD, a renowned microbiologist who has led infectious disease efforts at leading research institutions, has been appointed the first Chief Scientific Officer at Mass Eye and Ear, a member hospital of Mass General Brigham, following an extensive search.

22-Feb-2021 3:20 PM EST
International Team Identifies 127 Glaucoma Genes in Largest Study of Its Kind
Massachusetts Eye and Ear

In the largest genome-wide association study of glaucoma to date, an international team of researchers compared the genes of 34,179 people with the disease to 349,321 control subjects. They identified 127 genes linked to glaucoma, including 44 new gene loci and confirmed 83 previously reported loci.

27-Jan-2021 2:05 PM EST
AAVCOVID Releases Preclinical Data on Single-Dose, Room Temperature-Stable COVID-19 Vaccine Supported by New Funding
Massachusetts Eye and Ear

The AAVCOVID vaccine program, a novel gene-based vaccine strategy that utilizes an adeno-associated virus (AAV) vector, was granted an award for up to $2.1 million from the Bill & Melinda Gates Foundation. In data released in preprint, two AAVCOVID vaccine candidates led to robust neutralizing antibody responses in mouse and nonhuman primate models from only a single dose. The candidates were also shown to be safe and well-tolerated in both models.

Released: 20-Jan-2021 9:00 AM EST
Head and Neck Imaging Expert Appointed Chief of Radiology at Mass Eye and Ear
Massachusetts Eye and Ear

Dr. Mary Beth Cunnane, a radiologist who specializes in the imaging of patients with diseases of the eyes, ears, nose and head and neck, has been appointed Chief of Radiology at Mass Eye and Ear in Boston.

Released: 6-Jan-2021 12:00 AM EST
Antibiotics Not Needed After Most Sinus Surgeries According to Randomized Controlled Trial
Massachusetts Eye and Ear

A new randomized controlled trial has found antibiotics are not necessary after routine sinus surgery for preventing infection and optimizing patient outcomes.

1-Dec-2020 5:15 PM EST
Scientists Reverse Age-Related Vision Loss, Eye Damage From Glaucoma in Mice
Massachusetts Eye and Ear

Proof-of-concept study represents first successful attempt to reverse the aging clock in animals through epigenetic reprogramming.

18-Nov-2020 3:05 PM EST
Mass Eye and Ear Experts Urge Food and Drug Administration to Allow Over-The-Counter Hearing Aid Devices
Massachusetts Eye and Ear

Hearing experts advocate in The New England Journal of Medicine for the FDA to implement the Over-the-Counter Hearing Aid Act of 2017. The FDA missed the deadline to release the much-anticipated regulations on August 18, 2020

Released: 29-Oct-2020 2:55 PM EDT
Mass Eye and Ear Capital Campaign Concludes with $252 Million Raised to Advance Research and Patient Care
Massachusetts Eye and Ear

Mass Eye and Ear is proud to announce the successful conclusion of its historic campaign, “Bold Science. Life-Changing Cures.” which raised $252M from philanthropy to advance research to treat and cure diseases of vision, hearing, and the head and neck. The campaign was led by co-chair Wyc Grousbeck, Boston Celtics CEO and Lead Owner and former Chairman of Mass Eye and Ear.

Released: 28-Sep-2020 3:00 PM EDT
New Artificial Intelligence Platform Uses Deep Learning to Diagnose Dystonia with High Accuracy in Less Than One Second
Massachusetts Eye and Ear

Researchers at Mass Eye and Ear have developed a unique diagnostic tool called DystoniaNet that uses artificial intelligence to detect dystonia from MRI scans in 0.36 seconds. DystoniaNet is the first technology of its kind to provide an objective diagnosis of the disorder. In a new study of 612 brain MRI scans, the platform diagnosed dystonia with 98.8 percent accuracy.

15-Sep-2020 2:10 PM EDT
Mass Eye and Ear Receives $4 Million Gift to Accelerate Research on Genetic Links to Alzheimer’s Disease Resistance
Massachusetts Eye and Ear

Mass Eye and Ear has received a five-year, $4 Million gift from Good Ventures to spur Dr. Joseph F. Arboleda-Velásquez's groundbreaking work into Alzheimer’s disease genetic resistance. This transformational gift will enable Dr. Arboleda-Velásquez to build upon the recent discovery of a genetic mutation that protected a woman who had a high familial risk for the condition and amyloid plaque deposits in her brain against early-onset Alzheimer’s.

27-Aug-2020 1:25 PM EDT
Mass Eye and Ear Doctors Collaborate with Dana-Farber to Rebuild Damaged Corneas Using Patients’ Own Stem Cells for First Time in United States
Massachusetts Eye and Ear

Surgeons at Mass Eye and Ear have replaced the ocular surface of four patients who each experienced chemical burns to one eye by using their own stem cells taken from the other healthy eye, in a technique known as “cultivated autologous limbal epithelial cell transplantation” (CALEC). These four cases, all part of an ongoing clinical trial supported by the National Eye Institute of the NIH, represent the first procedures of their kind to occur in the United States.

15-Jul-2020 12:10 PM EDT
Study uncovers hair cell loss as underlying cause of age-related hearing loss
Massachusetts Eye and Ear

In a new study of human ear tissues, hearing scientists have demonstrated that age-related hearing loss, also called presbycusis, is mainly caused by damage to hair cells, the sensory cells in the inner ear that transform sound-induced vibrations into the electrical signals that are relayed to the brain by the auditory nerve. Their research challenges the prevailing view of the last 60 years that age-related hearing loss is mainly driven by damage to the stria vascularis, the cellular “battery” that powers the hair cell’s mechanical-to-electrical signal conversion.

2-Jul-2020 8:00 AM EDT
Massachusetts Eye and Ear Enters Licensing Agreement with Biogen to Develop Treatment for Inherited Retinal Disorder
Massachusetts Eye and Ear

Massachusetts Eye and Ear, a member hospital of Mass General Brigham, is entering into an exclusive licensing agreement with Biogen to develop a potential treatment for inherited retinal degeneration due to mutations in the PRPF31 gene, which are among the most common causes for autosomal dominant retinitis pigmentosa.

15-Jun-2020 1:30 PM EDT
Multispecialty Centers that Treat Pediatric Swallowing Disorders Deliver Better Outcomes and Reduced Health Care Costs Compared to Traditional Specialist Visits
Massachusetts Eye and Ear

Children who choke when they drink or eat may have what’s known as dysphagia, or a swallowing disorder -- one of the most common medical complaints seen in young children. A new study has found that by combining different medical disciplines in one center rather than a typical care journey making appointments one specialist at a time, children had better outcomes, reduced the number of procedures needed, and health care costs were reduced.

28-May-2020 8:00 AM EDT
AAVCOVID Vaccine Program Expands Manufacturing Agreements with Gene Therapy Industry Partners Viralgen, Aldevron, and Catalent
Massachusetts Eye and Ear

The AAVCOVID vaccine program at Massachusetts Eye and Ear and Massachusetts General Hospital has entered into manufacturing agreements with Viralgen, Aldevron and Catalent in order to support manufacturing of the experimental vaccine for clinical studies in the second half of 2020.

28-May-2020 8:00 AM EDT
AAVCOVID Vaccine Program from Mass. Eye and Ear and Mass General Enters Manufacturing Agreement with Gene Therapy Leader AveXis, a Novartis Company
Massachusetts Eye and Ear

AveXis, will lead the manufacturing efforts of the new AAVCOVID vaccine, utilizing its cutting-edge AAV technology for treatment of rare and life-threatening neurological genetic diseases. AveXis has the option to manufacture the AAV vaccine for additional clinical development, registration and/or commercial activities.

28-May-2020 8:00 AM EDT
Gene Therapy Program at Penn Medicine Joins AAVCOVID Vaccine Project
Massachusetts Eye and Ear

The internationally-renowned Gene Therapy Program at the University of Pennsylvania is joining the AAVCOVID vaccine program led by Massachusetts Eye and Ear and Massachusetts General Hospital (MGH), members of Mass General Brigham. AAVCOVID is a unique gene-based vaccine candidate designed to protect against SARS-CoV-2, the virus that causes COVID-19.

Released: 20-May-2020 10:45 AM EDT
Conference of Boston Teaching Hospitals Emergency Medical Services Committee Recognizes National EMS Week 2020 with new “Thank You” Video.
Massachusetts Eye and Ear

The Emergency Medical Services (EMS) Committee of the Conference of Boston Teaching Hospitals is pleased to join our hospital Emergency Medicine colleagues, the American College of Emergency Physicians, the National Association of EMT’s, Governor Charles D. Baker and Lieutenant Governor Karyn Polito, and City of Boston Mayor Martin J. Walsh in celebrating National EMS Week 2020, commencing May 17th, 2020.

Released: 5-May-2020 8:00 AM EDT
Massachusetts Eye and Ear and Massachusetts General Hospital Advancing Novel Experimental Gene-based COVID-19 Vaccine, AAVCOVID
Massachusetts Eye and Ear

Massachusetts Eye and Ear and Massachusetts General Hospital (MGH), members of Mass General Brigham, today announced progress towards the testing and development of an experimental vaccine called AAVCOVID, a novel gene-based vaccine candidate against SARS-CoV2, the virus that causes COVID-19. The AAVCOVID Vaccine Program is a unique, gene-based vaccine strategy that uses adeno-associated viral (AAV) vector, a clinically established gene transfer technology leveraging the properties of a harmless viral carrier.

Released: 12-Feb-2020 9:00 AM EST
Conference of Boston Teaching Hospitals (COBTH) Statement on President’s FY 2021 Budget Proposal
Massachusetts Eye and Ear

The Conference of Boston Teaching Hospitals' Executive Director, Patricia McMullin, released the following statement in response to President Trump’s Fiscal Year 2021 budget request, which proposes significant cuts to federal spending critical to teaching hospitals, including the National Institutes of Health, Medicaid, and graduate medical education.

Released: 28-Jan-2020 11:15 AM EST
Biomarkers of Brain Function May Lead to Clinical Tests for Hidden Hearing Loss
Massachusetts Eye and Ear

A pair of biomarkers of brain function — one that represents “listening effort,” and another that measures ability to process rapid changes in frequencies — may help to explain why a person with normal hearing may struggle to follow conversations in noisy environments, according to a new study led by Massachusetts Eye and Ear researchers. The researchers hoped the study could inform the design of next-generation clinical testing for hidden hearing loss, a condition that cannot currently be measured using standard hearing exams.

Released: 23-Jan-2020 11:15 AM EST
Researchers Uncover Mechanism for How Common Gene Therapy Vectors Enter Cells
Massachusetts Eye and Ear

Researchers have identified a novel cellular entry factor for adeno-associated virus vector (AAV) types—the most commonly used viral vectors for in vivo gene therapy.

3-Dec-2019 8:05 PM EST
Reprogramming the Inner Ear to Regrow Hair Cells Shows Promise to be an Effective Target for Hearing Loss Treatments
Massachusetts Eye and Ear

Mass. Eye and Ear scientists report the identification of a new pathway linked to cell division in the ear. With this pathway, they were able to reprogram the inner ear’s cells to proliferate and regenerate hair cell-like cells in adult mouse models.

Released: 4-Nov-2019 11:05 AM EST
Researchers Identify Genetic Mutation Tied to Alzheimer’s Disease Protection
Massachusetts Eye and Ear

Researchers have identified a genetic mutation of the APOE Alzheimer’s disease gene that may provide protection against the neurological illness. The researchers hope this mutation may provide future prevention and treatment targets for Alzheimer’s and other neurodegenerative diseases.

Released: 16-Oct-2019 3:00 PM EDT
EPFL and researchers from Mass. Eye and Ear are developing next-generation hearing implants
Massachusetts Eye and Ear

Researchers from Massachusetts Eye and Ear, Harvard Medical School and a team of EPFL researchers have developed a conformable electrode implant that will allow people with a dysfunctional inner ear to hear again. This new technology would improve existing auditory brainstem implants, which have a number of shortcomings.

Released: 9-Oct-2019 4:05 PM EDT
Mass. Eye and Ear Raises More than $1.3 Million at 10th Annual Sense-ation! Gala
Massachusetts Eye and Ear

Massachusetts Eye and Ear raised more than 1.3 million at its 10th Annual Sense-ation! Gala on October 7, 2019, at the Westin Boston Waterfront. Guests were treated to a specially-arranged performance from cast members from Disney’s The Lion King, presented by Broadway In Boston.

3-Sep-2019 1:05 PM EDT
Sound Deprivation in One Ear Leads to Speech Recognition Difficulties
Massachusetts Eye and Ear

Chronic conductive hearing loss, which can result from middle-ear infections, has been linked to speech recognition deficits, according to a new study led by scientists at Massachusetts Eye and Ear.

Released: 7-Aug-2019 1:05 PM EDT
Conference of Boston Teaching Hospitals Names Patricia (Tish) McMullin of Boston as new Executive Director
Massachusetts Eye and Ear

The Conference of Boston Teaching Hospitals, Inc. (COBTH) has named Patricia (Tish) McMullin, Esq, as the organization’s next Executive Director, effective in September. McMullin succeeds John Erwin who, after serving 13 years in the role, left last December to become Vice Chancellor for Government Affairs at UMass Medical School. COBTH is a coalition of 12 Boston-area teaching hospitals that collaborate on issues fundamental to their missions of patient care, teaching, biomedical research and community health.

9-Jul-2019 1:05 PM EDT
Study Questions if Tongue-Tie Surgery for Breastfeeding Is Always Needed
Massachusetts Eye and Ear

New research raises questions as to whether too many infants are getting tongue-tie surgery to help improve breastfeeding, despite limited medical evidence supporting the procedure. In a new study of 115 newborns, nearly 63 percent of children who were referred for surgery ended up not needing the procedure following a thorough feeding evaluation.

Released: 1-May-2019 8:00 AM EDT
Massachusetts Eye and Ear Names Dr. David S. Friedman Director of Glaucoma Service
Massachusetts Eye and Ear

Mass. Eye and Ear is pleased to welcome David S. Friedman, MD, MPH, PhD, as Director of the Glaucoma Service, Co-Director of the Ophthalmology Glaucoma Center of Excellence, Medical Director of Clinical Research at Mass. Eye and Ear, and a member of the full-time faculty of the Harvard Medical School Department of Ophthalmology. Dr. Friedman will be the first incumbent of the Albert and Diane Kaneb Chair in Ophthalmology at Mass. Eye and Ear.

22-Apr-2019 10:05 AM EDT
Microglia, the Immune Cells of the Central Nervous System, Shown to Regulate Neuroinflammation
Massachusetts Eye and Ear

A research team at Massachusetts Eye and Ear has shown that microglia, the immune cells of the central nervous system—including the retina —serve as “gatekeepers” of neuroinflammation. Uveitis is one of the leading causes of blindness worldwide. In the study published in Proceedings of the National Academy of Sciences (PNAS), researchers describe for the first time a role for microglia in directing the initiation of autoimmune uveitis by orchestrating the inflammatory response within the retina.

Released: 18-Apr-2019 8:00 AM EDT
New Chief Medical Officer Starts at Massachusetts Eye and Ear
Massachusetts Eye and Ear

Aalok Agarwala, MD, MBA, has been appointed the new Chief Medical Officer of Massachusetts Eye and Ear, and joined the senior leadership team April 1 in this new role.


Showing results

150 of 196

close
0.56014